Re: OssaTron "double blind"

Posted by Gina on 12/27/98
I think the double blind relates to weeding out people who know that the "real" treatment may be painful. Same with whoever is administering treatments; they may or may not be the doctors promoting this product. I don't think we have any idea of the effectiveness of ossatron based on the few people who have had it and post to this site. The point of the FDA studies is to ultimately have a fairly large, random sample of people and then compare improvement between the overall groups receiving and not receiving treatment. I wouldn't make any judgments until all the FDA studies are completed and results tabulated. 16:49:53

Follow Ups To This Message:

Post A Followup To This Message:

E-Mail: (optional)
Modify the subject heading below to summarize your response.